The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1101
April 2, 2001
View Complete Issue         Table of Contents 2019 
Issue 1101
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Prozac Weekly
April 2, 2001 (Issue: 1101)
The FDA has approved a new formulation of fluoxetine for once-weekly maintenance treatment of depression in patients who have responded to daily fluoxetine (Prozac).
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1101
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.